Regulation of Microglia Phenotypes in Alzheimer’s Disease

Principal Investigator
Johannes Schlachetzki, MD
University of California, San Diego
La Jolla, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2024 - June 30, 2027
Grant ID
A2024038S
Goals
The goal of our project is to define transcription factors that drive microglial phenotypes associated with plaques, neurofibrillary tangles, and neurodegeneration in Alzheimer’s disease.
Summary
Alzheimer’s disease is defined by the accumulation of harmful proteins in the brain. Microglia, the immune cells of the brain, play a key role in this process, but the molecular mechanisms that lead to distinct phenotypes are unclear. This study will use advanced techniques to isolate and analyze microglia, revealing how they contribute to disease and identifying new targets for developing effective treatments. We will test the hypothesis that specific groups of protein families (MiT/TFE and AP-1), are responsible for controlling the genes that microglia turn on or off in Alzheimer’s disease.
Unique and Innovative
By combining multi-omic approaches (ATAC-seq, ChIP-seq, RNA-seq), we can nominate transcription factor candidates that drive gene expression of microglia associated with Alzheimer’s disease pathology. We can then directly test their impact on microglia function and potentially shift microglia into a beneficial phenotype.
Foreseeable Benefits
At the end of the study, we will have identified transcription factors implicated in driving altered microglia gene expression in Alzheimer’s disease. We will also have a better understanding of the interplay between microglia phenotypes and Alzheimer’s disease pathology. This knowledge will ultimately lead to new treatment avenues targeting neuroinflammation in Alzheimer’s disease.
Grants
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Dong Kyu Kim, PhD
Defining the Impact of Cytokine Signaling in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Dong Kyu Kim, PhD
Alzheimer's Disease Research
Cancer-Like Metabolic Changes in Alzheimer's Disease Neurons
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Jerome Mertens, PhD
Cancer-Like Metabolic Changes in Alzheimer's Disease Neurons
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Jerome Mertens, PhD